Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 360 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pharmacist intervention Clear all

Conditions: Staphylococcus Aureus Infections
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Bronchiolitis
Interventions: 3% Hypertonic Saline, 0.9 % normal saline; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 2 Months to 12 Months
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Kidney Disease, Hypertension
Interventions: Protocolized, pharmacist-delivered CKD Action Plan; Other
Lead sponsor: Geisinger Clinic; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Opioid Use, Unspecified
Interventions: EMC2 Strategy, SMS Text Reminders; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 652 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Yellow Fever
Interventions: Yellow fever vaccine, Deuterium (70% enriched 2H2O) labeled water; Biological · Other
Lead sponsor: Sri Edupuganti; Other
Eligibility: 18 Years to 45 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Off-label Use of Atypical Antipsychotic Drugs
Interventions: Toolkit only with Web Access to Online Version, Toolkit, Periodic Audit/Feedback, Educational Messages, Items in Arm 2 plus Academic Detailing Program; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Rocky Hill, Connecticut

Conditions: Diabetes Mellitus, Cardiovascular Diseases
Interventions: Algorithm driven medication titration, Monitoring, Group support, Self efficacy; Other · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: West Haven, Connecticut • Honolulu, Hawaii • Providence, Rhode Island

Conditions: Hypertension, Diabetes Mellitus
Interventions: CVRS Intervention; Behavioral
Lead sponsor: Korey Kennelty; Other
Eligibility: 18 Years and older
Enrollment: 542 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 14
States / cities: Pocatello, Idaho • Chicago, Illinois • Mahomet, Illinois + 11 more

Conditions: Diabetes, Hypertension, Hypercholesterolemia
Interventions: Pharmacist calls patient unless physician cancels call, Patient nonadherence information sent to physician, Pharmacist calls patient if physician requests call, Doctor receives information and may be allowed certain actions; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 2,697 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Diabetes
Interventions: Adherence information, Adherence information plus motivational interviewing; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 1,692 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sleep Deprivation, Critical Illness, Sleep-Wake Disorders, Bundle Care, Implementation Science, Delirium
Interventions: Nighttime noise & light reduction, Clustering patient-care interactions, Non-pharmacologic sleep aids, Daytime light exposure, Encourage out-of-bed activity, Medication management to support nighttime sleep; Behavioral · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 62,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 7
States / cities: La Jolla, California • San Francisco, California • Orlando, Florida + 4 more

Conditions: Kidney Failure, Chronic
Interventions: Deprescribing Intervention; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 55 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetes
Interventions: Intervention Phone Call; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Acute Kidney Injury
Interventions: Vancomycin, Piperacillin-tazobactam, Cefepime; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Dementia, Alzheimer Disease, Dementia, Vascular, Lewy Body Disease, Frontotemporal Lobar Degeneration, Memory Disorders
Interventions: Navigated Care; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 45 Years and older
Enrollment: 1,560 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: San Francisco, California • Omaha, Nebraska

Conditions: Communication Research
Interventions: Med Wise Rx; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 65 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Eau Claire, Wisconsin • Greendale, Wisconsin • Kenosha, Wisconsin + 1 more

Conditions: Hypertension, Renal Insufficiency, Chronic
Interventions: Clinical Decision Support System (CDSS), Clinic Decision Sup System + Pharmacist; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 542 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Illness, Cognitive Impairment
Interventions: MD2 machine and nurse care coordination, Medplanner and Nurse Care Coordination; Other
Lead sponsor: Arizona State University; Other
Eligibility: 60 Years and older
Enrollment: 414 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Diabetes, Hypertension, Hyperlipidemia, Heart Diseases, Depression, Psychoses
Interventions: pharmacist contact with the patient via telephone, Pharmacist contact with the patient's physician via fax, Usual care; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: Not listed
Enrollment: 3,048 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hypertension
Interventions: Best Practice Clinic-Based Care, Telehealth Care; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 85 Years
Enrollment: 3,071 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Bloomington, Minnesota

Conditions: Gestational Diabetes Mellitus, Pre-diabetes, Diabetes Mellitus, Type 2
Interventions: Shared decision-making for diabetes prevention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 54 Years · Female only
Enrollment: 310 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Los Angeles, California • Salt Lake City, Utah

Conditions: Type 2 Diabetes, Vitamin B12 Deficiency, Neuropathy, Anemia
Interventions: Office visit intervention, Electronic Message Intervention; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hypertension, Hypercholesterolemia, Dementia Risk Factors
Interventions: Angiotensin Receptor Blockers (ARBs), Hydrophilic Statins or Non-Statin Alternative; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 50 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Medication Adherence, Hypertension
Interventions: My Interprofessional Care team for Adherence and Research Engagement (MI-CARE); Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Springfield, Massachusetts

Search by objective public record fields.

Impact of Rapid Detection of MRSA

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis

Early Identification and Action in CKD

EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use

Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine

iADAPT: Off Label Use of Antipsychotics in the Nursing Home

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Dissemination of the Cardiovascular Risk Service

Pharmacy Home Adherence Reporting and Monitoring Outcomes Study

Multi-arm Intervention Diabetes Adherence Study

Sleep Harmonization Via Bundled Team-Based Interventions in the ICU

Deprescribing for Older Dialysis Patients

SUPREME-DM (Diabetes Mellitis) Treatment Study

A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients

Care Ecosystem: Navigating Patients and Families Through Stages of Care

Optimizing Medication Management by Older Adults Through the Med Wise Rx Community-based Program

Evaluation of an Electronic CKD Clinical Decision Support System (CDSS) in Clinical Care

Home Care Medication Management Program for the Frail Elderly

Pharmacy Interventions to Improve Chronic Disease Medication Refill

Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure

A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus

Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin

Vascular Intervention Strategies Trial for Alzheimer's

My Interprofessional Care Team for Adherence and Research Engagement Disparities